Skip to content

Effects of a home-based motor care program with remote and presential monitoring in individuals with Amyotrophic Lateral Sclerosis: randomized clinical trial

Effects of an optimized respiratory and motor care protocol in patients with Amyotrophic Lateral Sclerosis: randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10z9pgfv
Enrollment
Unknown
Registered
2021-02-05
Start date
2021-11-25
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis, muscle fatigue

Interventions

Experimental Group (EG): Participants in the experimental group and their caregivers will receive a booklet containing guidelines regarding the home exercise protocol that should be performed, with re
Q65.060

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: This study will include definite, probable, or possible participants with ALS of both sexes, diagnosed by a neurologist, according to the criteria of El Escorial criteria, aged between 18 and 80 years, and able to understand and perform simple motor instructions according to verbal commands

Exclusion criteria

Exclusion criteria: Bedridden participants under continuous use of non-invasive ventilation and those who need but do not have caregivers available will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Functional capacity verified by the Amyotrophic Lateral Sclerosis Functional Classification Scale - Revised. Patients will be classified according to the decline in the total score (= 30 and> 30)

Secondary

MeasureTime frame
Muscle fatigue verified by the Fatigue Severity Scale, where values below 28 points are indicative of the presence of fatigue;Disease severity assessed using the Amyotrophic Lateral Sclerosis Severity Scale, with a score of 40 to 4, which represent, respectively, normal function and worse function.;Assessment of pain level, static and dynamic, using the Visual Analogue Scale, scored from 1 to 10, according to the reported pain intensity, and identified by the location indicated in the body diagram

Countries

Brazil

Contacts

Public ContactAline Souza

Universidade Federal do Rio Grande do Norte

alvss.aline@gmail.com+55 (84) 99819-8935

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 12, 2026